Nuzenio

Drugsorb

Drugsorb news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 6 latest news signals 4 publisher sources 100/100 entity strength

Latest news

Timeline

Fri, 07 Aug 2026 20:07:30 GMTCytoSorbents (NASDAQ: CTSO) posts Q2 2026 revenue of $9.6M and narrows loss - Stock Titan
Fri, 07 Aug 2026 06:44:00 GMTCytoSorbents Q2 2026: Flat Revenue, Improved Cash Burn Ahead of DrugSorb-ATR FDA Decision - The Clinical Trial Vanguard
Thu, 06 Aug 2026 22:54:45 GMTCTSO: Gross margin improved to 73% as cash burn fell, with regulatory and commercial progress ongoing - TradingView
Thu, 06 Aug 2026 21:43:51 GMTCytoSorbents Q2 2026 earnings: Margins improve despite flat revenue - TradingKey
Thu, 06 Aug 2026 20:25:00 GMTCytoSorbents plans early-2027 FDA filing for blood-thinner device - Stock Titan
Fri, 31 Jul 2026 07:00:00 GMTCTSO|Cytosorbents Corp|Price:0.358|Chg%:-0.003 - TradingKey

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Drugsorb.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

4 distinct publisher/source names are currently connected to this entity page.